Sign in to view content

The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections

Kapil Mishra, MD

Video
Published 2021

Related

Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020
COVID-19, Journal Club with Drs. Ajay Kuriyan and Yoshihiro Yonekawa
Jayanth Sridhar, MD
Member Podcasts
2020
New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
Alay S. Banker, MD
Annual Meeting Talks
2018

Category: Socioeconomics

See more